Mineralocorticoid Receptor Antagonists (MRAs) (Table 2): Mineralocorticoid receptor activation due to the upregulation of renin and angiotensin axis causes activation of inflammatory factors and fibrosis, which contribute to the progression of chronic kidney disease as well as congestive heart failure [36]. The gene discussed is NR3C2; the disease is chronic kidney disease.